recent advances

  • 文章类型: Journal Article
    背景:正颌手术带来了颌骨之间的和谐关系,从而改善面部美学。关键是分析使用虚拟手术计划进行正颌手术是否可以获得满意的结果,以便将其推荐给常规临床实践。
    目的:本研究的目的是使用三维(3D)成像和虚拟手术计划软件评估正颌手术后发生的各种软组织变化,并量化虚拟手术计划软件对正颌手术患者的准确性。
    方法:这是一项观察性前瞻性研究,样本量为12。
    方法:在这项前瞻性研究中,根据纳入和排除标准,包括12名接受正颌手术的患者。进行了常规的术前检查,并使用该软件根据从患者获得的DICOM数据制定了面部骨骼的3D复制品,即,病人牙列的CT和扫描。完成了虚拟手术计划,并根据新达到的期望位置制造了夹板。患者按照计算机辅助设计和计算机辅助制造(CAD-CAM)夹板指导的虚拟手术计划进行手术。术后评估。由于这项研究更多的是描述性研究,以获得新程序的详细知识,只有一组正在研究中,因此本研究未纳入统计检验.
    结果:软组织点叠加后发现的平均差异为0.92,标准偏差为0.3。
    结论:3DCT虚拟手术计划是在正颌外科手术病例中实现可预测和可靠的术后结果的可靠工具。
    BACKGROUND: Orthognathic surgery brings about a harmonious relationship between jaws, resulting in improved facial aesthetics. It is key to analyze if satisfactory results can be attained by using virtual surgical planning for orthognathic procedures so as to recommend it for routine clinical practice.
    OBJECTIVE: The aims of this study were to evaluate the various soft tissue changes that take place following orthognathic surgery using three-dimensional (3D) imaging and virtual surgical planning software and quantify the accuracy of virtual surgical planning software on patients undergoing orthognathic surgery.
    METHODS: This is an observational prospective study with a sample size of 12.
    METHODS: In this prospective study, 12 patients undergoing orthognathic surgery were included following the inclusion and exclusion criteria. A usual pre-surgical work-up was done and a 3D replica of the facial skeleton was formulated using the software with the DICOM data acquired from the patient i.e., CT and scans of patient\'s dentition. Virtual surgical planning was done and splints were manufactured according to the desired newly achieved position. Patients were operated following the virtual surgical plan guided by the computer-aided design and computer-aided manufacturing (CAD-CAM) splints. Post-operative evaluation was done. As the study is more of a descriptive study to obtain detailed knowledge of a new procedure, only one group is being studied and hence there is no statistical testing included in this study.
    RESULTS: The mean discrepancy noticed after superimposition of soft tissue points was 0.92 with a standard deviation of 0.3.
    CONCLUSIONS: 3D CT virtual surgical planning is a reliable tool to achieve predictable and reliable post-operative results in orthognathic surgical cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    锂二氧化碳(Li-CO2)电池,以其大约2.8V的高放电电压和1876Whkg-1的大量理论比能量而著称,代表了新能源和减少CO2排放的有希望的途径。然而,这些电池的实际应用面临重大障碍,特别是在高电流密度和延长的循环寿命下,由于其复杂的反应机理和缓慢的动力学。本文深入研究了Li-CO2电池阴极催化剂的最新进展,特别关注构图的设计哲学,几何图形,和催化剂的均匀性,以适当的测试条件和实际应用。它调查了可能的催化机制,向读者简要介绍了能量是如何储存和释放的,以及对材料性能和性能之间关系的批判性探索。具体来说,优化和标准化Li-CO2电池研究的测试条件,以提高数据的可比性,这对于促进Li-CO2电池的实际应用也至关重要。这篇综述旨在从以前的工作中获得灵感,以推进更有效和可持续的阴极催化剂的设计,为满足Li-CO2电池的实际需求而量身定制。
    Lithium carbon dioxide (Li-CO2) batteries, noted for their high discharge voltage of approximately 2.8 V and substantial theoretical specific energy of 1876 Wh kg-1, represent a promising avenue for new energy sources and CO2 emission reduction. However, the practical application of these batteries faces significant hurdles, particularly at high current densities and over extended cycle lives, due to their complex reaction mechanisms and slow kinetics. This paper delves into the recent advancements in cathode catalysts for Li-CO2 batteries, with a specific focus on the designing philosophy from composition, geometry, and homogeneity of the catalysts to the proper test conditions and real-world application. It surveys the possible catalytic mechanisms, giving readers a brief introduction of how the energy is stored and released as well as the critical exploration of the relationship between material properties and performances. Specifically, optimization and standardization of test conditions for Li-CO2 battery research is highlighted to enhance data comparability, which is also critical to facilitate the practical application of Li-CO2 batteries. This review aims to bring up inspiration from previous work to advance the design of more effective and sustainable cathode catalysts, tailored to meet the practical demands of Li-CO2 batteries.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    阿尔茨海默病是一种神经退行性问题,伴随着记忆和其他认知功能障碍的进行性丧失,导致神经递质活动和信号传导进程的失衡。这就需要潜在的治疗靶点来改善激酶带来的细胞内信号级联。蛋白激酶在阿尔茨海默病的治疗中起着重要和多方面的作用,通过靶向病理机制,如tau过度磷酸化,神经炎症,β淀粉样蛋白的产生和突触功能障碍。在这次审查中,我们彻底探索了与阿尔茨海默病有关的必需蛋白激酶,详细说明他们的生理角色,监管影响,以及正在进入临床试验的最新抑制剂和化合物。所有的研究结果都显示了激酶抑制剂在阿尔茨海默病治疗中的有希望的作用。然而,对于激酶抑制剂治疗阿尔茨海默病的未来前景,它仍然需要解决当前与该疾病有关的挑战和机遇。进一步的研究包括生物标志物的开发,联合治疗,和下一代激酶抑制剂具有更高的效力和选择性,为其未来的前景。
    Alzheimer\'s disease is a neurodegenerative problem with progressive loss of memory and other cognitive function disorders resulting in the imbalance of neurotransmitter activity and signaling progression, which poses the need of the potential therapeutic target to improve the intracellular signaling cascade brought by kinases. Protein kinase plays a significant and multifaceted role in the treatment of Alzheimer\'s disease, by targeting pathological mechanisms like tau hyperphosphorylation, neuroinflammation, amyloid-beta production and synaptic dysfunction. In this review, we thoroughly explore the essential protein kinases involved in Alzheimer\'s disease, detailing their physiological roles, regulatory impacts, and the newest inhibitors and compounds that are progressing into clinical trials. All the findings of studies exhibited the promising role of kinase inhibitors in the management of Alzheimer\'s disease. However, it still poses the need of addressing current challenges and opportunities involved with this disorder for the future perspective of kinase inhibitors in the management of Alzheimer\'s disease. Further study includes the development of biomarkers, combination therapy, and next-generation kinase inhibitors with increased potency and selectivity for its future prospects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    由于质谱技术的进步,植物激素研究最近取得了重大进展。如今,植物激素组学是一个完全整合的科学领域,专注于植物激素的分析,主要是因为他们与世隔绝,植物的鉴定和时空定量。这篇综述代表了过去十年中通过质谱进行植物激素分析的进展的全面荟萃研究。为了应对当前趋势和未来前景,系统收集了WebofScience数据,并使用多变量数据分析方法评估了关键特征,例如基于质谱的分析。我们的发现表明,植物激素组学目前分为靶向和非靶向方法。两者都旨在使样本小型化,允许高分辨率定量被覆盖在植物器官以及亚细胞区室中。因此,我们可以研究植物激素的生物合成,时空分辨率下的代谢和信号传导。此外,这种趋势最近已经加速了技术进步,如荧光激活细胞分选或质谱成像。
    Due to technological advances in mass spectrometry, significant progress has been achieved recently in plant hormone research. Nowadays, plant hormonomics is well established as a fully integrated scientific field focused on the analysis of phytohormones, mainly on their isolation, identification and spatiotemporal quantification in plants. This review represents a comprehensive meta-study of the advances in the phytohormone analysis by mass spectrometry over the past decade. To address current trends and future perspectives, Web of Science data were systematically collected and key features such as mass spectrometry-based analyses were evaluated using multivariate data analysis methods. Our findings showed that plant hormonomics is currently divided into targeted and untargeted approaches. Both aim to miniaturize the sample, allowing high-resolution quantification to be covered in plant organs as well as subcellular compartments. Therefore, we can study plant hormone biosynthesis, metabolism and signalling at a spatio-temporal resolution. Moreover, this trend has recently been accelerated by technological advances such as fluorescence-activated cell sorting or mass spectrometry imaging.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    抑郁症,一种常见的精神疾病,严重影响个人健康,对社会产生有害影响。抑郁症的预防和治疗引起了众多研究者的关注,成为一个重要的社会问题。抑郁症的治疗策略包括药物,心理治疗,和物理治疗。药物治疗在某些患者中无效,心理治疗具有治疗局限性。作为一种可靠的辅助治疗,理疗弥补了药物和心理治疗的不足,有效降低了疾病的复发率。理疗更加科学严谨,它的方法多种多样,在某种程度上,为抑郁症的治疗提供了更多的选择。物理治疗可以在许多方面缓解症状,例如通过提高神经生化分子的水平,抑制炎症反应,调节神经内分泌系统,增加神经可塑性。物理治疗具有与抗抑郁药相似的生物学效应,当与其他治疗方法结合使用时,可能会产生叠加的影响。本文总结了过去五年来使用物理疗法治疗抑郁症患者的发现。从临床疗效方面探讨了治疗抑郁症的几种理疗方法,作用机制,和缺点,从而为物理治疗研究的深入发展提供参考。
    Depression, a common mental illness, seriously affects the health of individuals and has deleterious effects on society. The prevention and treatment of depression has drawn the attention of many researchers and has become an important social issue. The treatment strategies for depression include drugs, psychotherapy, and physiotherapy. Drug therapy is ineffective in some patients and psychotherapy has treatment limitations. As a reliable adjuvant therapy, physiotherapy compensates for the shortcomings of drug and psychotherapy and effectively reduces the disease recurrence rate. Physiotherapy is more scientific and rigorous, its methods are diverse, and to a certain extent, provides more choices for the treatment of depression. Physiotherapy can relieve symptoms in many ways, such as by improving the levels of neurobiochemical molecules, inhibiting the inflammatory response, regulating the neuroendocrine system, and increasing neuroplasticity. Physiotherapy has biological effects similar to those of antidepressants and may produce a superimposed impact when combined with other treatments. This article summarizes the findings on the use of physiotherapy to treat patients with depression over the past five years. It also discusses several methods of physiotherapy for treating depression from the aspects of clinical effect, mechanism of action, and disadvantages, thereby serving as a reference for the in-depth development of physiotherapy research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    天花是三千多年来死亡的重要原因,每年占死亡人数的10%。EdwardJenner于1796年发现了天花疫苗接种,该疫苗迅速成为全世界的天花感染预防措施,并在1980年根除了天花感染。根除天花后,猴痘疫苗主要用于非洲的研究和疫情,这种疾病是地方病。在目前,这些疫苗被用于与动物或高风险地区一起工作的人,以及治疗猴痘患者的医护人员。在所有正痘病毒(OPXV)中,猴痘病毒(MPXV)感染主要发生在食蟹猴,天然水库,偶尔会导致人类严重的多器官感染,谁是偶然的宿主。2022年5月7日发现了目前流行的第一例MXPV,并迅速增加了病例数。在这方面,世界卫生组织宣布爆发,2022年7月23日国际突发公共卫生事件。第一个猴痘疫苗是20世纪60年代由美国陆军研制的,以痘苗病毒为基础,也用于天花疫苗。近年来,新的猴痘疫苗已经开发基于其他病毒,如改良的牛痘安卡拉(MVA)。这些新型疫苗更安全,可以提供更持久的免疫力,副作用更少。为了未来,目前正在进行研究,以改进目前的疫苗和开发新的疫苗。一个值得注意的进步是开发了使用遗传修饰的痘苗病毒表达猴痘抗原的重组疫苗。该疫苗在临床前试验中显示出了有希望的结果,目前正在临床试验中进行进一步的测试。最近的另一个发展是使用DNA疫苗,将编码猴痘抗原的遗传物质直接送入细胞。这种类型的疫苗已在动物研究中显示出有效性,并且正在人类中进行临床试验。总的来说,猴痘疫苗开发的这些最新进展有望保护个体免受这种潜在严重疾病的侵害。
    Smallpox was a significant cause of mortality for over three thousand years, amounting to 10% of deaths yearly. Edward Jenner discovered smallpox vaccination in 1796, which rapidly became a smallpox infection preventive practice throughout the world and eradicated smallpox infection by 1980. After smallpox eradication, monkeypox vaccines have been used primarily in research and in outbreaks in Africa, where the disease is endemic. In the present, the vaccines are being used for people who work with animals or in high-risk areas, as well as for healthcare workers treating patients with monkeypox. Among all orthopoxviruses (OPXV), monkeypox viral (MPXV) infection occurs mainly in cynomolgus monkeys, natural reservoirs, and occasionally causes severe multi-organ infection in humans, who were the incidental hosts. The first case of the present epidemic of MXPV was identified on May 7, 2022, and rapidly increased the number of cases. In this regard, the WHO declared the outbreak, an international public health emergency on July 23, 2022. The first monkeypox vaccine was developed in the 1960s by the US Army and was based on the vaccinia virus, which is also used in smallpox vaccines. In recent years, newer monkeypox vaccines have been developed based on other viruses such as Modified Vaccinia Ankara (MVA). These newer vaccines are safer and can provide longer-lasting immunity with fewer side effects. For the future, there is ongoing research to improve the current vaccines and to develop new ones. One notable advance has been the development of a recombinant vaccine that uses a genetically modified vaccinia virus to express monkeypox antigens. This vaccine has shown promising results in pre-clinical trials and is currently undergoing further testing in clinical trials. Another recent development has been the use of a DNA vaccine, which delivers genetic material encoding monkeypox antigens directly into cells. This type of vaccine has shown effectiveness in animal studies and is also undergoing clinical testing in humans. Overall, these recent advances in monkeypox vaccine development hold promise for protecting individuals against this potentially serious disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    肌腱是连接肌肉和骨骼的成纤维细胞结构。有两种肌腱损伤,包括急性和慢性。每种形式的损伤或恶化都会导致明显的疼痛和肌腱功能丧失。肌腱损伤的恢复是一个复杂而耗时的恢复过程。根据肌腱组织的解剖位置,临床结果不一样.伤口愈合过程分为三个重叠阶段:炎症,扩散,和组织重塑。此外,固化肌腱具有高的再撕裂率。面对挑战,肌腱损伤的处理仍然是一个必须尽快解决的临床问题。近年来,肌腱恢复出现了几个新的方向和突破。本文介绍了肌腱损伤,并总结了肌腱恢复的最新进展,随着干细胞治疗,基因治疗,富含血小板的血浆药物,生长因子,药物治疗,和组织工程。尽管最近在肌腱恢复治疗方面的研究快速增长,仍然,它们都没有转化为临床环境。这篇综述提供了肌腱损伤和治疗肌腱损伤的潜在临床前方法的详细概述。
    Tendons are fibroblastic structures that link muscle and bone. There are two kinds of tendon injuries, including acute and chronic. Each form of injury or deterioration can result in significant pain and loss of tendon function. The recovery of tendon damage is a complex and time-consuming recovery process. Depending on the anatomical location of the tendon tissue, the clinical outcomes are not the same. The healing of the wound process is divided into three stages that overlap: inflammation, proliferation, and tissue remodeling. Furthermore, the curing tendon has a high re-tear rate. Faced with the challenges, tendon injury management is still a clinical issue that must be resolved as soon as possible. Several newer directions and breakthroughs in tendon recovery have emerged in recent years. This article describes tendon injury and summarizes recent advances in tendon recovery, along with stem cell therapy, gene therapy, Platelet-rich plasma remedy, growth factors, drug treatment, and tissue engineering. Despite the recent fast-growing research in tendon recovery treatment, still, none of them translated to the clinical setting. This review provides a detailed overview of tendon injuries and potential preclinical approaches for treating tendon injuries.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    近年来,龋齿的管理有了显着发展。基于风险指标和风险因素评估的诊断,早期识别,龋齿预防是一些最新有效的策略。本概述简要介绍了龋齿预防策略的最新进展。
    Management of dental caries has seen a significant development in recent years. A diagnosis based on risk indicators and risk factor assessments, early identification, and caries prevention are some of the most recent and efficient strategies. The recent advancements in dental caries prevention strategies are briefly covered in this overview.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究的目的是比较无图像机器人和常规全膝关节置换术(TKA)的短期临床和放射学结果,并通过分析TKA后的异常值来评估两种技术的准确性。我们已经评估了200个连续的膝盖(158名患者),100个膝盖接受机器人TKA,和100个膝盖用常规TKA治疗。人口参数,如年龄,性别,身体质量指数,获得了诊断和运动范围。膝关节社会评分(KSS)和膝关节社会功能评分(KSS-F)用于临床评估。机械对准(髋-膝-踝角度),胫骨近端角(MPTA),我们分析了股骨远端角度(LDFA)和胫骨斜度的放射学结果,并比较了两组的异常值.当在最终随访射线照片上的每个放射学测量中,测量的角度与中性对齐超过±3°时,定义了异常值。最短随访时间为6个月(范围,6至18个月)。机器人组术前平均HKA角度为169.7±11.3°,常规组为169.3±7.3°。HKA有显著改善,LDFA,两组的MPTA和胫骨斜率与术前值比较(p<0.01)。HKA的数量,LDFA和胫骨坡度异常值分别为31、29和37,与机器人组的13、23和17相比(p<0.01)。两组术后KSS和KSS-F功能评分均有显著改善(p<0.01)。然而,两组术后功能评分无显著差异(p=0.08).这项研究显示了无图像机器人和传统TKA的出色改进,两组的临床结局相似。然而,与常规TKA相比,放射机器人TKA显示出更好的准确性和一致性,且异常值更少.
    The aim of this study was to compare the short term clinical and radiological outcomes of imageless robotic and conventional total knee arthroplasty (TKA) and to estimate the accuracy of the two techniques by analysing the outliers after TKA. We have evaluated 200 consecutive knees (158 patients), 100 knees undergoing robotic TKA, and 100 knees treated with conventional TKA. Demographic parameters like age, gender, body mass index, diagnosis and range of motion were obtained. Knee society score (KSS) and Knee society functional score (KSS-F) were used for clinical evaluation. Mechanical alignment (Hip-knee-ankle angle), proximal tibial angle (MPTA), distal femoral angle (LDFA) and tibial slope were analysed for radiological results and outliers were compared between both groups. Outliers were defined when the measured angle exceeded ± 3° from the neutral alignment in each radiological measurement on the final follow-up radiograph.The minimum follow-up was 6 months (range, 6 to 18 months). The preoperative mean HKA angle was 169.7 ± 11.3° in robotic group and 169.3 ± 7.3° in conventional group. There was significant improvement in HKA, LDFA, MPTA and tibial slope compared to the preoperative values in both the groups (p < 0.01). The number of HKA, LDFA and tibial slope outliers were 31, 29 and 37, respectively, in the conventional group compared to 13, 23 and 17 in the robotic group (p < 0.01). There was a significant improvement in the KSS and KSS-F functional scores postoperatively in both the groups (p < 0.01). However, there was no significant difference in the functional scores between the groups postoperatively (p = 0.08). This study showed excellent improvement with both imageless robotic and conventional TKA, with similar clinical outcomes between both groups. However, radiologically robotic TKA showed better accuracy and consistency with fewer outliers compared with conventional TKA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    骨科手术的最新进展极大地改善了肌肉骨骼疾病和损伤的管理。这篇综述讨论了骨科中出现的最新治疗方法。我们研究了再生医学的使用,包括干细胞治疗和富血小板血浆(PRP)注射,加速愈合,促进组织再生。此外,我们探索机器人辅助手术的应用,在手术过程中提供更高的精度和准确性。我们还深入研究了个性化医疗的出现,根据个体患者独特的遗传和环境因素为他们量身定制治疗方法。此外,我们讨论了远程医疗和远程患者监护作为改善患者预后和降低医疗成本的方法.最后,我们研究了在骨科中使用人工智能和机器学习的日益增长的兴趣,特别是在诊断和治疗计划方面。总的来说,这些治疗方法的进步显着改善了患者的预后,减少恢复时间,并提高了骨科手术的整体护理质量。
    Recent advancements in orthopedic surgery have greatly improved the management of musculoskeletal disorders and injuries. This review discusses the latest therapeutic approaches that have emerged in orthopedics. We examine the use of regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) injections, to accelerate healing and promote tissue regeneration. Additionally, we explore the application of robotic-assisted surgery, which provides greater precision and accuracy during surgical procedures. We also delve into the emergence of personalized medicine, which tailors treatments to individual patients based on their unique genetic and environmental factors. Furthermore, we discuss telemedicine and remote patient monitoring as methods for improving patient outcomes and reducing healthcare costs. Finally, we examine the growing interest in using artificial intelligence and machine learning in orthopedics, particularly in diagnosis and treatment planning. Overall, these advancements in therapeutic approaches have significantly improved patient outcomes, reduced recovery times, and enhanced the overall quality of care in orthopedic surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号